| Name | Title | Contact Details |
|---|
NYMOZARFEX (TM) is given in an in-office procedure that is administered in a few minutes without need of anesthesia or analgesia. The drug has been tested in clinical trials involving overall more than 1750 patients with over 1600 injections administered including over 1200 Fexapotide administrations. Fexapotide has led to significant long-term improvements and has shown an excellent safety profile without the side effects normally associated with existing BPH treatments.
Catalyst Institute is a Westborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Vono Medical Supplies is a Springfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Access Plans USA, Inc. (Access Plans) develops and distributes health care programs for individuals, and employer groups. Its products and programs include health insurance plans and non-insurance health care discount programs.
Innovasa Corporation is a Eugene, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.